Background: There is a well-established association between idiopathic inflammatory myopathies (IIM) and malignancy. are no evidence-based guidelines amongst neurologists rheumatologists on the choice timing of malignancy investigations. Our aim to characterize current gaps uncertainties with screening in IIM patients. Methods: An online survey consisting 18 multiple-choice questions related wa...